Fritextsökning
Innehållstyper
-
Pharma-on-Demand
Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...
-
The best wealth is Health
We are living in a world where wealth more and more is measured in being able to do the things you like and enjoy in life. As the wealth increases in terms of e...
-
TV: Astrazeneca väljer Sverige
Och vill se fler life science-grannar i Göteborg
-
Han är ny HR-chef på E-hälsomyndigheten
I mitten av februari tillträdde Johan Jervehed som ny chef för myndighetens HR-avdelningen.
-
Nano-antikropp från alpacka blockerade coronavirus
Ett fragment av en antikropp från en alpacka verkar kunna blockera det nya corona-viruset från att ta sig in i celler.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
Academia - a strong player on the lab market
While the industry was short of money during the financial crisis, government incentives were in full swing in Sweden during 2009. - Our sales to academia incre...
-
From spin-off to phase II
”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.
-
Biden utser coronateam – hans rådgivare kritiserar Tegnell
USA:s nya president Joe Biden intar en helt ny hållning i bekämpningen av covid-19 än sin företrädare. Hans rådgivare Andy Slavitt kritiserade nyligen Anders Te...
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
Anna Törner: You won’t find this many Concorde projects anywhere else
"Suddenly Concorde projects seem reasonable in life science because it´s about life and death", writes Anna Törner in a column.
-
Globalt uttalande
Pfizers globala uttalande efter patentgodkännande av Prevenar 13 i Indien.
-
Before you choose a CRO
– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of De...
-
Astrapreparat bra vid by-pass
En klinisk studie från Uppsala Clinical Research Centre visar fördelar med Astras preparat jämfört med standardbehandlingen.
-
IRW Consulting is seeking Clinical Research Associates (CRAs) on positions located in Stockholm
-
Svenska innovationer visas upp på Arab Health
The Innovation Pavilion by Sweden invigdes den 29 januari i närvaro av särskilt inbjudna gäster från regionen, representanter från Socialdepartementet, Sveriges...
-
Saving lives worldwide with low-cost molecular diagnostics
High throughput testing for many upper respiratory tract pathogens thanks to automation technology
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
Swedenbios nya vd om uppdraget
"Fantastiskt kul och hedervärt"
-
Giulia Gaudenzi: ”Key lessons from global health research”
The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.
-
Brighter förlänger erbjudandet
Ger mer tid till Division By Zeros aktieägare att acceptera bolagets köperbjudande.
-
Ska utveckla tudelad affärsmodell
Neurovive utser Mark Farmery till chef för affärsutveckling.
-
Your partnering tool - step by step
Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!